These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18032543)

  • 1. Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.
    Bowman SJ; Sutcliffe N; Isenberg DA; Goldblatt F; Adler M; Price E; Canavan A; Hamburger J; Richards A; Rauz S; Regan M; Gadsby K; Rigby S; Jones A; Mathew R; Mulherin D; Stevenson A; Nightingale P
    Rheumatology (Oxford); 2007 Dec; 46(12):1845-51. PubMed ID: 18032543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.
    Barry RJ; Sutcliffe N; Isenberg DA; Price E; Goldblatt F; Adler M; Canavan A; Hamburger J; Richards A; Regan M; Gadsby K; Rigby S; Jones A; Mathew R; Mulherin D; Stevenson A; Nightingale P; Rauz S; Bowman SJ
    Rheumatology (Oxford); 2008 Aug; 47(8):1193-8. PubMed ID: 18524804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool.
    Bowman SJ; Booth DA; Platts RG;
    Rheumatology (Oxford); 2004 Jun; 43(6):758-64. PubMed ID: 15039495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in primary Sjogren's syndrome: comparison of the long and short versions of the Profile of Fatigue and Discomfort--Sicca Symptoms Inventory.
    Bowman SJ; Hamburger J; Richards A; Barry RJ; Rauz S
    Rheumatology (Oxford); 2009 Feb; 48(2):140-3. PubMed ID: 19074185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of fatigue in primary Sjögren's syndrome: the Swedish version of the Profile of Fatigue.
    Strömbeck B; Theander E; Jacobsson LT
    Scand J Rheumatol; 2005; 34(6):455-9. PubMed ID: 16393768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.
    Westhoff G; Dörner T; Zink A
    Rheumatology (Oxford); 2012 Feb; 51(2):262-9. PubMed ID: 21705778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome measures for primary Sjögren's syndrome: a comprehensive review.
    Seror R; Theander E; Bootsma H; Bowman SJ; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Mariette X; Vitali C
    J Autoimmun; 2014 Jun; 51():51-6. PubMed ID: 24411404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of fatigue and dryness in primary Sjögren's syndrome: Brazilian version of "Profile of Fatigue and Discomfort - Sicca Symptoms Inventory (short form) (PROFAD-SSI-SF)".
    Miyamoto ST; Paganotti MA; Serrano ÉV; Giovelli RA; Valim V
    Rev Bras Reumatol; 2015; 55(2):113-22. PubMed ID: 25582994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinimetric methods in Sjögren's syndrome.
    Hernández-Molina G; Sánchez-Hernández T
    Semin Arthritis Rheum; 2013 Jun; 42(6):627-39. PubMed ID: 23352255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcultural adaptation of the "EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)" into Brazilian Portuguese.
    Serrano EV; Valim V; Miyamoto ST; Giovelli RA; Paganotti MA; Cadê NV
    Rev Bras Reumatol; 2013; 53(6):483-93. PubMed ID: 24477727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
    Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
    Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Sjögren's syndrome in children and adolescents: are proposed diagnostic criteria applicable?
    Houghton K; Malleson P; Cabral D; Petty R; Tucker L
    J Rheumatol; 2005 Nov; 32(11):2225-32. PubMed ID: 16265707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue and blood pressure in primary Sjogren's syndrome.
    d'Elia HF; Rehnberg E; Kvist G; Ericsson A; Konttinen Y; Mannerkorpi K
    Scand J Rheumatol; 2008; 37(4):284-92. PubMed ID: 18612929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.
    Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G
    Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
    Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
    Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Hamburger J; Richards A; Rauz S; Emery P
    Ann Rheum Dis; 2008 Nov; 67(11):1541-4. PubMed ID: 18276741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.